Redeye updates its view on Amniotics following the 2023 rights issue and new strategy focusing on bu...
Redeye comments on Energy Save’s Q3’22/23 report, which once again showed superior growth (157% y/y)...
Redeye concludes that Q4 was weaker than expected. Revenue was 5% below expectations, where recurrin...
Nordea released Finnish card spending data until end of February today.
En förvärvare av högkvalitativa bolag inom media och tech Vi inleder bevakning av VO2 Cap Holding, e...
Recyctec fortsätter växa med ett fortsatt fokus på försäljning, både på den inhemska och utländska m...
2023e order book forecast increased by 4% 2023e-24e revenue, EBIT (before s.
Redeye believes the new biomarker results with nadunolimab to be presented at the AACR Annual Meetin...
I samband med att aXichem AB (publ) (”aXichem” eller ”Bolaget”) genomför sin företrädesemission har ...
DT has signed an agreement to acquire Shanghai Haobo Imaging Technology, an X-ray flat panel detecto...
Starkt tredje kvartal Systemair redovisar fortsatt stark tillväxt i Q3’22/23.
Långsammare rekrytering för ABNCoV2 fas 3-studie, utspädningseffekter samt lägre prognoser sänker mo...
Redeye comments on W5’s announcement that it has signed a letter of intent to acquire Kongsberg Targ...
Ban could result in reduced growth for EFUEL-15% '23e group EBIT impact.
Redeye endorses the positive results announced by InDex Pharmaceuticals regarding the PK study in pa...
BioArctic: Subvention från US Veteran Health Administration och marknadspresentation från Eisai.
Cantargia is a clinical-stage biotechnology company with lead asset nadunolimab (CAN04) under assess...
Fiskars is a global home for design-driven indoor and outdoor living brands.
Redeye initiates coverage of Scandinavian ChemoTech, a Swedish medtech company in early-stage commer...
